Brand-name drug
Trulicity price, strengths & recalls
Brand of dulaglutide (generic)
Pharmacies pay $975.29 for 2 mL of Trulicity 1.5 mg/mL, 0.5 mL auto-injector this week, and from $974.83 to $975.29 across its 4 priced strengths and forms. It has 3 recalls on record, none ongoing. Its official label last changed on August 10, 2026.
Medicare price 2028Brand- Fair cash price
- $1,132.08
- Strengths
- 4
- Makers
- 1
- Updated
- Nov 11
Trulicity price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 1.5 mg/mL, 0.5 mL auto-injector Brand | $487.65 | $975.29 / 2 mL |
| 3 mg/mL, 0.5 mL auto-injector Brand | $487.62 | $975.24 / 2 mL |
| 6 mg/mL, 0.5 mL auto-injector Brand | $487.56 | $975.12 / 2 mL |
| 9 mg/mL, 0.5 mL auto-injector Brand | $487.42 | $974.83 / 2 mL |
Trulicity vs generic dulaglutide
There is no generic version of Trulicity on the market yet.
GenericDulaglutide pricesMedicare negotiated price
Trulicity was selected for Medicare price negotiation. Its negotiated price takes effect on January 1, 2028; the price itself is published by the end of November 2026.
What this means for patients
- The negotiated price is what Medicare Part D plans pay for the drug - not your price at the counter.
- What you pay depends on your plan's copay or coinsurance and where you are in the year. Coinsurance (a percentage) falls with the price; a flat copay may not change at all.
- Out-of-pocket costs for Part D drugs are capped each year ($2,100 in 2026), whatever the drug.
- If you don't have Medicare, the negotiated price doesn't apply to you - check the fair cash price above instead.
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Trulicity
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use TRULICITY safely and effectively. See full prescribing information for TRULICITY.TRULICITY (dulaglutide) injection, for subcutaneous useInitial U.S. Approval: 2014
WARNING: RISK OF THYROID C-CELL TUMORS
In male and female rats, dulaglutide causes a dose-related and treatment-duration-dependent increase in the incidence of thyroid C-cell tumors (adenomas and carcinomas) after lifetime exposure. It is unknown whether TRULICITY causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of dulaglutide-induced rodent thyroid C-cell tumors has not been determined
[see Warnings and Precautions (5.1), and Nonclinical Toxicology (13.1)].
TRULICITY is contraindicated in patients with a personal or family history of MTC and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk of MTC with use of TRULICITY and inform them of symptoms of thyroid tumors (e.g., mass in the neck, dysphagia, dyspnea, persistent hoarseness). Routine monitoring of serum calcitonin or using thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with TRULICITY
[see Contraindications (4) and Warnings and Precautions (5.1)].
WARNING: RISK OF THYROID C-CELL TUMORS
See full prescribing information for complete boxed warning.
Dulaglutide causes thyroid C-cell tumors in rats. It is unknown whether TRULICITY causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of dulaglutide-induced rodent thyroid C-cell tumors has not been determined (5.1, 13.1).
TRULICITY is contraindicated in patients with a personal or family history of MTC and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk of MTC and symptoms of thyroid tumors (4, 5.1).
Recent major changes (as listed on the label)
Warnings and Precautions
|
| Severe Gastrointestinal Adverse Reactions (5.6)
| 03/2026
|
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- BLA125469 · Eli Lilly And Co
- First approved
- September 18, 2014 (12 years ago)
- Latest approved change
- March 12, 2026
- Approved label
- PDF, Mar 18, 2026
- Generic makers
- None on the market
Trulicity questions
How much does trulicity cost without insurance?
Pharmacies pay about $975.29 for 2 mL of trulicity 1.5 mg/mL, 0.5 mL auto-injector ($487.65 per mL). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $1,132.08. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Trulicity?
Yes: dulaglutide. Compare dulaglutide prices.
Is trulicity in shortage?
No shortage is reported for trulicity right now. We check the national shortage list every day.
Has trulicity been recalled?
3 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the trulicity label last change?
The official label was last updated on August 10, 2026 (version 62). See what changed.
Does Medicare have a negotiated price for Trulicity?
Yes - Trulicity was selected and its negotiated price starts January 1, 2028.
Talk about trulicity
No comments yet. Questions, tips, what worked for you - start the conversation.